Business Wire

Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update

Poziotinib NDA accepted for FDA review in previously treated patients with NSCLC harboring HER2 exon 20 insertion mutations, PDUFA date November 24, 2022 Positive poziotinib results in treatment naïve ...
Business Wire

Spectrum Pharmaceuticals Presentations at the Upcoming AACR Virtual Meeting 2021 to Include Updated Poziotinib Twice Daily Dosing Data

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation on ...
The Desert Sun

Charter Spectrum will raise cable TV, home phone prices for many customers in June

Most Charter Spectrum cable TV and home telephone customers can expect to pay more starting in June. The nation’s second-largest cable operator is notifying customers about a monthly price increase ...
Nasdaq

Spectrum Pharmaceuticals Presents Late Breaker Oral Presentation of Poziotinib Data in First-Line NSCLC Patients with HER2 Exon 20 Insertion Mutations at ESMO Congress 2021

Early data from Cohort 4 of the ongoing ZENITH20 clinical trial shows ORR of 44% in 48 first-line patients treated with 16mg of poziotinib once daily ZENITH20 Trial Design and Early Safety and ...
USA Today

Charter Spectrum to raise cable TV and home phone prices for many customers in June

Most Charter Spectrum cable TV and home telephone customers can expect to pay more starting in June. The nation’s second-largest cable operator is notifying customers about a monthly price increase ...